Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

147 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy, tolerability and safety of a split-dose bowel cleansing regimen of magnesium citrate with sodium picosulfate - a phase IV clinical observational study.
Bor R, Matuz M, Fabián A, Szepes Z, Szántó K, Farkas K, Rutka M, Milassin Á, Pigniczki D, Bálint A, Tóth T, Molnár T. Bor R, et al. Among authors: szanto k. Rev Esp Enferm Dig. 2021 Sep;113(9):635-642. doi: 10.17235/reed.2020.7073/2020. Rev Esp Enferm Dig. 2021. PMID: 33371690 Free article. Clinical Trial.
Infliximab biosimilar CT-P13 therapy is effective and safe in maintaining remission in Crohn's disease and ulcerative colitis - experiences from a single center.
Farkas K, Rutka M, Ferenci T, Nagy F, Bálint A, Bor R, Milassin Á, Fábián A, Szántó K, Végh Z, Kürti Z, Lakatos PL, Szepes Z, Molnár T. Farkas K, et al. Among authors: szanto k. Expert Opin Biol Ther. 2017 Nov;17(11):1325-1332. doi: 10.1080/14712598.2017.1363885. Epub 2017 Aug 18. Expert Opin Biol Ther. 2017. PMID: 28819991
The Use of Complementary and Alternative Medicine Is Less Frequent in Patients with Inflammatory Bowel Disease Than in Patients with Other Chronic Gastrointestinal Disorders.
Fábián A, Rutka M, Ferenci T, Bor R, Bálint A, Farkas K, Milassin Á, Szántó K, Lénárt Z, Nagy F, Szepes Z, Molnár T. Fábián A, et al. Among authors: szanto k. Gastroenterol Res Pract. 2018 Apr 3;2018:9137805. doi: 10.1155/2018/9137805. eCollection 2018. Gastroenterol Res Pract. 2018. PMID: 29849602 Free PMC article.
Infliximab biosimilar CT-P13 therapy is effective in maintaining endoscopic remission in ulcerative colitis - results from multicenter observational cohort.
Bálint A, Rutka M, Kolar M, Bortlik M, Duricova D, Hruba V, Lukas M, Mitrova K, Malickova K, Lukas M, Szepes Z, Nagy F, Palatka K, Lovas S, Végh Z, Kürti Z, Csontos Á, Miheller P, Nyári T, Bor R, Milassin Á, Fábián A, Szántó K, Lakatos PL, Molnár T, Farkas K. Bálint A, et al. Among authors: szanto k. Expert Opin Biol Ther. 2018 Nov;18(11):1181-1187. doi: 10.1080/14712598.2018.1530758. Epub 2018 Oct 9. Expert Opin Biol Ther. 2018. PMID: 30277084
Real-life efficacy of vedolizumab on endoscopic healing in inflammatory bowel disease - A nationwide Hungarian cohort study.
Bor R, Fábián A, Matuz M, Szepes Z, Farkas K, Miheller P, Szamosi T, Vincze Á, Rutka M, Szántó K, Bálint A, Nagy F, Milassin Á, Tóth T, Zsigmond F, Bajor J, Müllner K, Lakner L, Papp M, Salamon Á, Horváth G, Sarang K, Schäfer E, Sarlós P, Palatka K, Molnár T. Bor R, et al. Among authors: szanto k. Expert Opin Biol Ther. 2020 Feb;20(2):205-213. doi: 10.1080/14712598.2020.1699529. Epub 2019 Dec 6. Expert Opin Biol Ther. 2020. PMID: 31782939
147 results